help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haugen, B. R.
Right arrow Articles by Ridgway, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugen, B. R.
Right arrow Articles by Ridgway, E. C.
Molecular Endocrinology 11 (4): 481-489
Copyright © 1997 by The Endocrine Society

The Thyrotrope-Restricted Isoform of the Retinoid-X Receptor-{gamma}1 Mediates 9-cis-Retinoic Acid Suppression of Thyrotropin-ß Promoter Activity

Bryan R. Haugen, Nicole S. Brown, William M. Wood, David F. Gordon and E. Chester Ridgway

Division of Endocrinology, Diabetes, and Metabolism Department of Medicine University of Colorado Health Sciences Center Denver, Colorado 80262

TSHß is a subunit of TSH that is uniquely expressed and regulated in the thyrotrope cells of the anterior pituitary gland. Thyroid hormone receptors (TR) are known to mediate T3 suppression of TSHß gene expression at the level of promoter activity. The role of other nuclear receptors in regulation of this gene is less clearly defined. Retinoid X receptors (RXR) are a family of nuclear transcription factors that function both as 9-cis-retinoic acid (RA) ligand-dependent receptors and heterodimeric partners with TR and other nuclear receptors. Recently, the RXR isoform, RXR{gamma}, has been identified in the anterior pituitary gland and found to be restricted to thyrotrope cells within the pitutiary. In this report, we have further characterized the distribution of RXR{gamma}1, the thyrotrope-restricted isoform of RXR{gamma}, in murine tissues and different cell types. We have found that RXR{gamma}1 mRNA and protein are expressed in the TtT-97 thyrotropic tumor, but not the thyrotrope-variant {alpha}TSH cells or somatotrope-derived GH3 cells. Furthermore, we have studied the effects of RXR{gamma}1 on TSHß promoter activity and hormone regulation in these pituitary-derived cell types. Both T3 and 9-cis-RA independently suppressed promoter activity in the TtT-97 thyrotropes. Interestingly, the combination of ligands suppressed promoter activity more than either alone, indicating that these hormones may act cooperatively to regulate TSHß gene expression in thyrotropes. The RXR{gamma}1 isoform was necessary for the 9-cis-RA-mediated suppression of TSHß promoter activity in {alpha}TSH and GH3 cells, both of which lack this isoform. RXRß, a more widely distributed isoform, did not mediate these effects. Finally, we showed that the murine TSHß promoter region between -200 and -149 mediated a majority of the 9-cis-RA suppression of promoter activity in thyrotropes. This region is distinct from the T3-mediated response region near the transcription start site. These data suggest that retinoids can mediate TSHß gene regulation in thyrotropes and the thyrotrope-restricted isoform, RXR{gamma}1, is required for this effect.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. B Zimmermann, P. L Jooste, N. S. Mabapa, S. Schoeman, R. Biebinger, L. F Mushaphi, and X. Mbhenyane
Vitamin A supplementation in iodine-deficient African children decreases thyrotropin stimulation of the thyroid and reduces the goiter rate
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1040 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. A. Smit, M. P. M. Stokkel, A. M. Pereira, J. A. Romijn, and T. J. Visser
Bexarotene-Induced Hypothyroidism: Bexarotene Stimulates the Peripheral Metabolism of Thyroid Hormones
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2496 - 2499.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Biebinger, M. Arnold, W. Langhans, R. F. Hurrell, and M. B. Zimmermann
Vitamin A Repletion in Rats with Concurrent Vitamin A and Iodine Deficiency Affects Pituitary TSH{beta} Gene Expression and Reduces Thyroid Hyperstimulation and Thyroid Size
J. Nutr., March 1, 2007; 137(3): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. M. Golden, K. B. Weber, T. L. Hernandez, S. I. Sherman, W. W. Woodmansee, and B. R. Haugen
Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjects
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 124 - 130.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LXIII. Retinoid X Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 760 - 772.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Sharma, W. R. Hays, W. M. Wood, U. Pugazhenthi, D. L. St. Germain, A. C. Bianco, W. Krezel, P. Chambon, and B. R. Haugen
Effects of Rexinoids on Thyrotrope Function and the Hypothalamic-Pituitary-Thyroid Axis
Endocrinology, March 1, 2006; 147(3): 1438 - 1451.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. B. Zimmermann, R. Wegmuller, C. Zeder, N. Chaouki, and T. Torresani
The Effects of Vitamin A Deficiency and Vitamin A Supplementation on Thyroid Function in Goitrous Children
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5441 - 5447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Takiyama, N. Miyokawa, A. Sugawara, S. Kato, K. Ito, K. Sato, K. Oikawa, H. Kobayashi, S. Kimura, and M. Tateno
Decreased Expression of Retinoid X Receptor Isoforms in Human Thyroid Carcinomas
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5851 - 5861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. B. McDermott, D. F. Gordon, C. A. Kramer, Q. Liu, E. Linney, W. M. Wood, and B. R. Haugen
Isolation and Functional Analysis of the Mouse RXRgamma 1 Gene Promoter in Anterior Pituitary Cells
J. Biol. Chem., September 20, 2002; 277(39): 36839 - 36844.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Liu, K. M. Ogilvie, K. Klausing, M. A. Lawson, D. Jolley, D. Li, J. Bilakovics, B. Pascual, N. Hein, M. Urcan, et al.
Mechanism of Selective Retinoid X Receptor Agonist-Induced Hypothyroidism in the Rat
Endocrinology, August 1, 2002; 143(8): 2880 - 2885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Macchia, P. Jiang, Y.-D. Yuan, R. A. S. Chandarardna, R. E. Weiss, O. Chassande, J. Samarut, S. Refetoff, and C. F. Burant
RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E326 - E331.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
S. X. Cheng and T. Kupper
A New Rexinoid for Cutaneous T-Cell Lymphoma
Arch Dermatol, May 1, 2001; 137(5): 649 - 652.
[Full Text] [PDF]


Home page
EndocrinologyHome page
T. Satoh, T. Ishizuka, T. Monden, N. Shibusawa, T. Hashida, M. Kishi, M. Yamada, and M. Mori
Regulation of the Mouse Preprothyrotropin-Releasing Hormone Gene by Retinoic Acid Receptor
Endocrinology, November 1, 1999; 140(11): 5004 - 5013.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
N. A. Rizvi, J. L. Marshall, W. Dahut, E. Ness, J. A. Truglia, G. Loewen, G. M. Gill, E. H. Ulm, R. Geiser, D. Jaunakais, et al.
A Phase I Study of LGD1069 in Adults with Advanced Cancer
Clin. Cancer Res., July 1, 1999; 5(7): 1658 - 1664.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. I. Sherman, J. Gopal, B. R. Haugen, A. C. Chiu, K. Whaley, P. Nowlakha, and M. Duvic
Central Hypothyroidism Associated with Retinoid X Receptor-Selective Ligands
N. Engl. J. Med., April 8, 1999; 340(14): 1075 - 1079.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Yusta, E. T. Alarid, D. F. Gordon, E. C. Ridgway, and P. L. Mellon
The Thyrotropin {beta}-Subunit Gene Is Repressed by Thyroid Hormone in a Novel Thyrotrope Cell Line, Mouse T{alpha}T1 Cells
Endocrinology, November 1, 1998; 139(11): 4476 - 4482.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Chin, J. Apriletti, and G. Gick
Characterization of a Negative Thyroid Hormone Response Element in the Rat Sodium, Potassium-Adenosine Triphosphatase {alpha}3 Gene Promoter
Endocrinology, August 1, 1998; 139(8): 3423 - 3431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-N. Wei, M. Farooqui, and X. Hu
Ligand-dependent Formation of Retinoid Receptors, Receptor-interacting Protein 140 (RIP140), and Histone Deacetylase Complex Is Mediated by a Novel Receptor-interacting Motif of RIP140
J. Biol. Chem., May 4, 2001; 276(19): 16107 - 16112.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society